Bristlecone Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.26M | Sell |
|
|||||
|
2025
Q2 | $1.83M | Sell |
|
|||||
|
2025
Q1 | $5.11M | Buy |
|
|||||
|
2024
Q4 | $4.43M | Buy |
|
|||||
|
2024
Q3 | $3.37M | Buy |
|
|||||
|
2024
Q2 | $2.55M | Buy |
|
|||||
|
2024
Q1 | $1.9M | Buy |
|
|||||
|
2023
Q4 | $304K | Sell |
|
|||||
|
2023
Q3 | $351K | Buy |
|
|||||
|
2023
Q2 | $387K | Buy |
|
|||||
|
2023
Q1 | $409K | Sell |
|
|||||
|
2022
Q4 | $564K | Buy |
|
|||||
|
2022
Q3 | $467K | Buy |
|
|||||
|
2022
Q2 | $542K | Sell |
|
|||||
|
2022
Q1 | $537K | Buy |
|
|||||
|
2021
Q4 | $611K | Buy |
|
|||||
|
2021
Q3 | $441K | Sell |
|
|||||
|
2021
Q2 | $421K | Sell |
|
|||||
|
2021
Q1 | $391K | Sell |
|
|||||
|
2020
Q4 | $463K | Sell |
|
|||||
|
2020
Q3 | $457K | Buy |
|
|||||
|
2020
Q2 | $368K | Sell |
|
|||||
|
2020
Q1 | $421K | Sell |
|
|||||
|
2019
Q4 | $1.21M | Buy |
|
|||||
|
2019
Q3 | $472K | Sell |
|
|||||
|
2019
Q2 | $1.36M | Buy |
|
|||||
|
2019
Q1 | $578K | Buy |
|
|||||
|
2018
Q4 | $474K | Buy |
|
|||||
|
2018
Q3 | $476K | Buy |
|
|||||
|
2018
Q2 | $213K | Sell |
|
|||||
|
2018
Q1 | $265K | Sell |
|
|||||
|
2017
Q4 | $398K | Buy |
|
|||||
|
2017
Q3 | $387K | Sell |
|
|||||
|
2017
Q2 | $406K | Sell |
|
|||||
|
2017
Q1 | $439K | Sell |
|
|||||
|
2016
Q4 | $430K | Sell |
|
|||||
|
2016
Q3 | $510K | Sell |
|
|||||
|
2016
Q2 | $688K | Sell |
|
|||||
|
2016
Q1 | $677K | Buy |
|
|||||
|
2015
Q4 | $633K | Buy |
|